Australia's international outlook, strong science base, multi-ethnic English-speaking population and high educational and regulatory standards make it an attractive location to undertake clinical trials for medicines and vaccines. These fundamentals were foregrounded during the COVID-19 pandemic, when Australia was able to pivot quickly and develop capabilities in technology and tele-monitoring in clinical trials, opening further opportunities for expanding its research base and patient populations into rural and regional areas.
See below for data on numbers of clinical trials, key categories, and funding sources, and to read more on opportunities in the country's life science industry post-COVID see here. If you are interested in more APAC datasets, download InFigures Asia-Pacific 2021 for free here.
Made with Visme Infographic Maker
Made with Visme Infographic Maker
Made with Visme Infographic Maker
